Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AE.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.504NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.201NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.221NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.410NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.411NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.513NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.338NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.284NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.9.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.498NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.184NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.187NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.110.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.342NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.500NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.511NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.428.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.506NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.482NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.335NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.499.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.116NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.134NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.393NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.381NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.526NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.279NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.38.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.76NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used